Schedule 13G ownership disclosure

MALLINCKRODT PLC

Security class unavailable · CUSIP: G5785G107

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
8,794,796
Percent of class
10.4900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-19-030418
Form type
SC 13G/A
Filer
Keenova Therapeutics plc
CIK
CIK 1567892
Filed
Jun 10, 2019
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub